
Results
2
2 companies
Newron Pharmaceuticals
Market Cap: CHF 301.8m
A biopharmaceutical company, discovers and develops novel therapies for patients with diseases of the central and peripheral nervous system in Italy and the United States.
NWRN
CHF 15.12
7D
6.5%
1Y
107.1%
Cosmo Pharmaceuticals
Market Cap: CHF 1.0b
Focuses on the development and commercialization products for gastroenterology, dermatology, and healthtech worldwide.
COPN
CHF 65.10
7D
4.3%
1Y
2.4%